Rapid Drug Development
Doctor Liu faced challenges in scaling up drug production despite his groundbreaking research. Recognizing the need for expertise in immunoinflammation and biopharmaceutical manufacturing, he quickly connected with key industry players, facilitating a swift acquisition by Merck. This collaboration aims to ensure timely treatment availability for hospitalized patients, with Operation Warp Speed negotiating to secure the necessary supply.In this clip
From this podcast
Prognosis: Misconception
The Doctor Behind the Government's Vaccine Deals
Related Questions